| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $233K | +15.3% |
| Cost of Revenue | $554K | -28.8% |
| Gross Profit | -$321K | +44.3% |
| R&D Expense | $13.9M | -15.0% |
| SG&A Expense | $14.9M | -18.5% |
| Operating Income | -$31.7M | +11.4% |
| Pre-tax Income | -$33.9M | +4.3% |
| Income Tax | $11K | +650.0% |
| Net Income | -$34.0M | +4.2% |
| EPS (Basic) | -$1.47 | +69.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.4M | +322.3% |
| Accounts Receivable | $77K | +600.0% |
| Inventory | $1.0M | +476.7% |
| Current Assets | $89.6M | +256.1% |
| Total Assets | $90.9M | +235.2% |
| Current Liabilities | $8.6M | -24.2% |
| Total Liabilities | $9.6M | -20.4% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.8M | -4.3% |
| Capital Expenditures | $109K | -77.6% |
| Investing Cash Flow | -$30.8M | -497.7% |
| Financing Cash Flow | $91.7M | +811.2% |
| Free Cash Flow | -$27.9M | -2.9% |
| $81.3M |
| +437.8% |